Agenda Released for Controlled Release Delivery: FDA, Janssen, GSK and Boehringer Ingelheim to Present Next April
SMi is thrilled to announce the release of the highly anticipated brochure for 14th annual Controlled Release Delivery taking place on 3rd to 4th of April in London.
London, United Kingdom, December 02, 2016 --(PR.com)-- Aimed at drug development experts and formulation specialists, Controlled Release Delivery 2017 will reflect on the latest innovations made within controlled release. The 2017 event will address the latest regulatory updates and how to overcome challenges within the industry. Key topics that will be explored include: innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.
The expert speaker line-up will feature:
Chairmen:
- Howard Stevens, Professor, University Of Strathclyde
- Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research
Featured Speakers:
- Markham Luke, Director, Division of Therapeutic Performance, FDA
- René Holm, Head and Scientific Director, Liquids & Parenterals, Janssen
- Mark Wilson, Director, Technology Licensing, PTS, GSK
- Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
- Stephan Buchmann, Head Preformulation & Preclinical Galenics, Actelion
- John Fox, Chief Executive Officer, Merrion Pharmaceuticals
- and many more...
Event highlights will include:
1. Listen to FDA evaluate generic drug development
2. Novartis optimise the success of biopharmaceutical approaches for controlled release delivery
3. Can lipid suspensions improve oral bioavailability? Answers from Janssen
4. Insights into the opportunities and limitations to improving solubility and bioavailability with Actelion
5. Hear InnoCore Pharmaceuticals discuss microparticles and hydrogels for parenteral drug delivery
A full speaker line-up and detailed conference agenda is available to download online at http://www.controlledreleasedelivery.com/prcom. For those looking to attend, there is currently a £400 discount available which expires on 16th December 2016.
Controlled Release Delivery
Strengthening innovation and overcoming the challenging regulatory landscape
3rd & 4th April 2017
London, UK
http://www.controlledreleasedelivery.com/prcom
Contact Information:
For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: zgale@smi-online.co.uk
To register for the conference, visit http://www.controlledreleasedelivery.com/prcom or contact Ameenah Begum on Tel: +44 (0)20 7827 6166 / Email: abegum@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
The expert speaker line-up will feature:
Chairmen:
- Howard Stevens, Professor, University Of Strathclyde
- Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research
Featured Speakers:
- Markham Luke, Director, Division of Therapeutic Performance, FDA
- René Holm, Head and Scientific Director, Liquids & Parenterals, Janssen
- Mark Wilson, Director, Technology Licensing, PTS, GSK
- Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
- Stephan Buchmann, Head Preformulation & Preclinical Galenics, Actelion
- John Fox, Chief Executive Officer, Merrion Pharmaceuticals
- and many more...
Event highlights will include:
1. Listen to FDA evaluate generic drug development
2. Novartis optimise the success of biopharmaceutical approaches for controlled release delivery
3. Can lipid suspensions improve oral bioavailability? Answers from Janssen
4. Insights into the opportunities and limitations to improving solubility and bioavailability with Actelion
5. Hear InnoCore Pharmaceuticals discuss microparticles and hydrogels for parenteral drug delivery
A full speaker line-up and detailed conference agenda is available to download online at http://www.controlledreleasedelivery.com/prcom. For those looking to attend, there is currently a £400 discount available which expires on 16th December 2016.
Controlled Release Delivery
Strengthening innovation and overcoming the challenging regulatory landscape
3rd & 4th April 2017
London, UK
http://www.controlledreleasedelivery.com/prcom
Contact Information:
For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: zgale@smi-online.co.uk
To register for the conference, visit http://www.controlledreleasedelivery.com/prcom or contact Ameenah Begum on Tel: +44 (0)20 7827 6166 / Email: abegum@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Zoe Gale
+44 (0) 20 7827 6166
http://www.controlledreleasedelivery.com/prcom
Zoe Gale
+44 (0) 20 7827 6166
http://www.controlledreleasedelivery.com/prcom
Contact
Categories